| 產品名稱 | Streptococcus agalactiae Lehmann and Neumann |
|---|---|
| 商品貨號 | B192386 |
| Strain Designations | M781 |
| Application | ATCC® BAA-22-MINI-PACK™ consists of 6 ready-to-use vials of ATCC® BAA-22™ frozen in 200 µL of glycerol stock, eliminating the need to rehydrate and culture the strain prior to use. Each vial is provided with a 2-D barcode for easy storage and tracking, as well as peel-off labels for fast and reliable recordkeeping. Learn more about ATCC® Minis  Developed by the leaders in microbial cultivation and preservation, ATCC® Minis provide a convenient, ready-to-use solution for handling quality control strains. ATCC® Minis are authenticated and backed by ATCC polyphasic testing – ensuring the same consistent and reliable reference materials you’ve come to trust for ATCC Genuine Cultures®. It is easy to ensure the quality of your products with ATCC® Minis – just open, plate, and go! .Produces capsular polysaccharide type III |
| Isolation | Cerebrospinal fluid of an infant with neonatal meningitis, 1978 |
| Biosafety Level | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Antigenic Properties | Serotype III |
| Product Format | frozen 6 ready-to-use vials of ATCC® BAA-22™ in glycerol stock |
| Storage Conditions | -70°C or colder, store upright. Storage at -20°C is acceptable for up to 1 year. |
| Preceptrol® | no |
| Type Strain | no |
| Medium | ATCC® Medium 44: Brain Heart Infusion Agar/Broth ATCC® Medium 260: Trypticase soy agar/broth with defibrinated sheep blood |
| Growth Conditions | Temperature: 37°C
Atmosphere: Aerobic |
| Name of Depositor | CJ Baker |
| Special Collection | NCRR Contract; ATCC® Minis |
| References | Anderson DC, et al. Impaired chemotaxigenesis by type III group B streptococci in neonatal sera: relationship to diminished concentration of specific anticapsular antibody and abnormalities of serum complement. Pediatr. Res. 17: 496-502, 1983. PubMed: 6348689 Kasper DL, et al. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J. Clin. Invest. 98: 2308-2314, 1996. PubMed: 8941648 BD MAX™ GBS Assay. BD Becton Dickinson. |
| 梅經理 | 17280875617 | 1438578920 |
| 胡經理 | 13345964880 | 2438244627 |
| 周經理 | 17757487661 | 1296385441 |
| 于經理 | 18067160830 | 2088210172 |
| 沈經理 | 19548299266 | 2662369050 |
| 李經理 | 13626845108 | 972239479 |
